Gadade, D.D. et al. 2018. CRYSTAL ENGINEERING OF ANTIVIRAL AGENT EFAVIRENZ FOR SOLUBILITY ENHANCEMENT. Journal of Drug Delivery and Therapeutics. 8, 1 (Jan. 2018), 86–91. DOI:https://doi.org/10.22270/jddt.v8i1.1637.